The Viral Vector Manufacturing Forum is a premier platform dedicated to addressing the critical challenges in the production of viral vectors, with a focus on AAV and lentiviral vectors—two of the most widely used delivery systems in gene therapy. As the demand for gene therapies continues to grow, the pressure on manufacturers to scale up production, enhance quality, and streamline processes has never been greater. This forum has been specifically designed to tackle these challenges head-on, providing a space for industry leaders, innovators, and stakeholders to collaborate, share insights, and develop strategies to accelerate advancements in viral vector manufacturing.
Manufacturing bottlenecks remain a significant hurdle in the journey to bring gene therapies to patients. From optimising vector design and upstream processes to addressing regulatory complexities and ensuring seamless scale-up, the forum will cover every aspect of viral vector production. The event aims to drive innovation and operational excellence by exploring the latest advancements in platform technologies, process intensification, and quality assurance.
This forum is not just an event—it is a mission-driven gathering focused on empowering the biopharmaceutical industry to meet the urgent demand for gene therapies by improving viral vector manufacturing. By fostering dialogue, sharing practical solutions, and showcasing emerging trends, the Viral Vector Manufacturing Forum helps bridge the gap between innovation and patient access, ultimately contributing to the delivery of life-changing therapies.
Join us to be part of this critical conversation and collaborate with global leaders who are shaping the future of gene therapy manufacturing. Together, we can overcome the challenges and drive the development of scalable, efficient, and high-quality viral vector production processes.
